Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

A Phase 2b Trial of EPB-348 for the Treatment of Herpes Zoster

This study has been completed.
Information provided by (Responsible Party):
Epiphany Biosciences Identifier:
First received: January 26, 2009
Last updated: December 3, 2013
Last verified: December 2013